“SEE-DRUG ” is a FP7 - RESEARH POTENTIAL project that aims to the upgrade the Structural Biology capacities of UPAT and to the Establishment of a Center of Excellence for Structure-Based Drug Target chracterization efforts in South-Eastern EU region.
Read the Full Story
“SEE-STRUCT” is structure-oriented module of SEE-DRUG project and aims to the structural elucidation of proteins, enzymes and other interesting drug-targets. The tools offered for these efforts are a state-of-the-art high field NMR instrument of 700 MHz equipped with a highly sensitive probe and crystallization robot. Read the Full Story
“SEE-PROT” & “SEE-PHARM” are the protein production and the preclinical evaluation of molecules, modules of SEE-DRUG project. The tools offered for these efforts are protein production and characterization facilities an upgraded confocal microscope, an intravital microscope and myographs. Read the Full Story
- 1Research Facilities
- 2Scientific Expertise
- 3Networking & Dissemination
Structural Biology NMR & Xray Applications
Expertise in NMR Structural Biology - (a) protein uniform, selective and/or specific labelling in 13C, 15N, 2H for advanced studies of high molecular weight biomolecules or complexes with NMR (SEE-STRUCT module), (b) NMR application specialists, for conformational dynamics studies of proteins and NMR-driven drug design efforts, set up of projection spectroscopy applications and data analysis (c) analysis of NMR data and protein structure determination, (d) NMR studies of paramagnetic metalloproteins, (e) screening with NMR spectroscopy the properties of the produced recombinant proteins (folding, solubility, stability, aggregation state, etc.), in order to increase the success rate in crystallization trials, (f) training of existed UPAT research staff in non-standard protocols for protein expression, isolation and/or labelling not currently available in UPAT and in Greek academia.
Expertise in Protein Crystallography and modelling – (a) crystal structure determination, and experience in drug design (SEE-STRUCT module), (b) experience in crystallization trials, crystallization screening conditions, and set up of the crystallization robot (sitting-drop vapour-diffusion crystallization experiments), (c) analysis of the NMR data concerning the experimental conditions and the suitability of proteins for crystallization trials, (d) experience in computational biology, biomolecular modeling (homology modeling & docking simulations), data mining and analysis.
Expertise in data acquisition/integration, database development and curation expert – set up of an integrated platform for the collection of the data from the collaborating groups; three individual databases for each one of the SEE-PROT, SEE-STRUCT, and SEE-PHARM modules facilitating the biological data modelling, handling and integration for relational (SQL-based) databases and related applications, requirement gathering, database design/data modelling and statistical analysis. Application of data handling standards for the data generated and also implement or guide the new data curation pipelines and tools.
Upcoming Events
- 2nd EAB Meeting 13th May 2013
- 2nd SEE-DRUG Workshop - NMR Basics & Applications in Life Sciences, May 13-15, 2013
- 1st EAB Meeting, 23 April, 2012
- 1st SEE-DRUG Workshop - From Chemical to Systems Biology, 9-10 May, 2012
- A list with Scientific Events, April-May 2012
Hot off the Press
Site Statistics
 | Today | 3 |
 | Yesterday | 21 |
 | This week | 76 |
 | Last week | 756 |
 | This month | 1615 |
 | Last month | 822 |
 | All days | 261906 |
Your IP: 18.118.1.232
,
Today: Apr 18, 2024
- 01 Jan 2012 Starting data of SEE-DRUG project
- 23 Feb 2012 Kick-off meeting
- 23 Apr2012 External Advisory Board meeting
- 29 Apr 2013 700MHz NMR installed